Stocks and InvestingStocks and Investing
Tue, November 30, 2021
Mon, November 29, 2021
Fri, November 26, 2021
Wed, November 24, 2021
Tue, November 23, 2021

Mani Foroohar Maintained (ARWR) at Hold with Increased Target to $45 on, Nov 23rd, 2021


Published on 2024-10-27 18:45:22 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $44 to $45 on, Nov 23rd, 2021.

Mani has made no other calls on ARWR in the last 4 months.



There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 0 agree with Mani's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mani


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $100 on, Tuesday, August 10th, 2021
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $94 on, Friday, August 6th, 2021